Literature DB >> 19869284

STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : I. ANTIBODY RESPONSE OF RABBITS IMMUNIZED WITH TYPE III PNEUMOCOCCUS.

W S Tillett1.   

Abstract

1. Type III pneumococci fail in the majority of instances to stimulate the production of anti-S antibodies. (Type specific agglutinins, type specific precipitins, and antibodies affording type specific protection in mice.) 2. Type III pneumococci are effective in the stimulation of the production of anti-P antibodies (agglutinins for R strains of pneumococci and precipitins for pneumococcus nucleoprotein). These antibodies are ineffectual in the passive protection of mice.

Entities:  

Year:  1927        PMID: 19869284      PMCID: PMC2131213          DOI: 10.1084/jem.45.4.713

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  THE SOLUBLE SPECIFIC SUBSTANCE OF PNEUMOCOCCUS.

Authors:  M Heidelberger; O T Avery
Journal:  J Exp Med       Date:  1923-06-30       Impact factor: 14.307

2.  SEROLOGICAL RELATIONSHIPS OF TYPE-SPECIFIC AND DEGRADED PNEUMOCOCCI.

Authors:  H A Reimann
Journal:  J Exp Med       Date:  1926-01-01       Impact factor: 14.307

3.  IMMUNOLOGICAL RELATIONSHIPS OF ENCAPSULATED AND CAPSULE-FREE STRAINS OF ENCAPSULATUS PNEUMONIAE (FRIEDLANDER'S BACILLUS).

Authors:  L A Julianelle
Journal:  J Exp Med       Date:  1926-10-31       Impact factor: 14.307

4.  AN IMMUNOLOGICAL STUDY OF PNEUMOCOCCUS MUCOSUS.

Authors:  F M Hanes
Journal:  J Exp Med       Date:  1914-01-01       Impact factor: 14.307

5.  IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS : SECOND PAPER.

Authors:  O T Avery; M Heidelberger
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

6.  IMMUNOLOGICAL REACTIONS OF THE ISOLATED CARBOHYDRATE AND PROTEIN OF PNEUMOCOCCUS.

Authors:  O T Avery; H J Morgan
Journal:  J Exp Med       Date:  1925-08-31       Impact factor: 14.307

7.  A NOTE ON THE PRODUCTION OF ANTIPNEUMOCOCCUS SERA.

Authors:  A B Wadsworth; M B Kirkbride
Journal:  J Exp Med       Date:  1917-05-01       Impact factor: 14.307

8.  THE PRODUCTION OF ANTIPNEUMOCOCCIC SERUM.

Authors:  R Cole; H F Moore
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

  8 in total
  8 in total

1.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : II. THE INFECTIVITY OF TYPE III PNEUMOCOCCUS FOR RABBITS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-05-31       Impact factor: 14.307

2.  ANTIPNEUMOCOCCIC IMMUNITY REACTIONS IN INDIVIDUALS OF DIFFERENT AGES.

Authors:  W D Sutliff; M Finland
Journal:  J Exp Med       Date:  1932-05-31       Impact factor: 14.307

3.  ACTIVE AND PASSIVE IMMUNITY TO PNEUMOCOCCUS INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R PNEUMOCOCCI.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1928-11-30       Impact factor: 14.307

4.  STUDIES ON IMMUNOLOGICAL RELATIONSHIPS AMONG THE PNEUMOCOCCI : II. A COMPARISON OF THE ANTIBODY RESPONSES OF MICE AND OF RABBITS TO IMMUNIZATION WITH TYPICAL TYPE III PNEUMOCOCCI AND TO IMMUNIZATION WITH A RELATED STRAIN.

Authors:  A L Harris; J Y Sugg; J M Neill
Journal:  J Exp Med       Date:  1928-05-31       Impact factor: 14.307

5.  STUDIES ON NATURAL IMMUNITY TO PNEUMOCOCCUS TYPE III : I. THE CAPACITY OF STRAINS OF PNEUMOCOCCUS TYPE III TO GROW AT 41 degrees C. AND THEIR VIRULENCE FOR RABBITS.

Authors:  J F Enders; M F Shaffer
Journal:  J Exp Med       Date:  1936-06-30       Impact factor: 14.307

6.  A STUDY OF THE MECHANISM OF RECOVERY FROM EXPERIMENTAL PNEUMOCOCCUS INFECTION.

Authors:  O H Robertson; S T Woo; S N Cheer; L P King
Journal:  J Exp Med       Date:  1928-01-31       Impact factor: 14.307

7.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : III. INCREASED RESISTANCE TO TYPE III INFECTION INDUCED IN RABBITS BY IMMUNIZATION WITH R AND S FORMS OF PNEUMOCOCCUS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-07-31       Impact factor: 14.307

8.  ANAPHYLAXIS WITH THE TYPE-SPECIFIC CARBOHYDRATES OF PNEUMOCOCCUS.

Authors:  O T Avery; W S Tillett
Journal:  J Exp Med       Date:  1929-01-31       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.